trial · primary record
iPSC-derived RPE/PLGA transplantation
Dry Age-Related Macular Degeneration
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2029-05-31 |
| Primary endpoint | Summary of adverse events |
| Registry ID | NCT04339764 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:38.718Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04339764
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.